Primary Record
189028-95-3
- In stock
- 2,534 g
- Purity
- 98.5 %
- CAS
- 189028-95-3
Compound Identifiers & Properties
- CAS
- 189028-95-3
- PubChem CID
- 10269700
- SMILES
- C1[C@@H](N(C(=O)O1)C(=O)CCC[C@@H](C2=CC=C(C=C2)F)O)C3=CC=CC=C3
- Canonical SMILES
- O=C(CCC[C@H](O)c1ccc(F)cc1)N1C(=O)OC[C@@H]1c1ccccc1
Names & Synonyms
- 189028-95-3
- ezetimibe int a
- (S)-3-((S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
- Ezetimibe Impurity A
- ezetimibe intermediates
- Ezetimibe Impurity 42
- Ezetimibe Impurity 47
- (4S)-3-[(5S)-5-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL]-4-PHENYL-1,3-OXAZOLIDIN-2-ONE
- Ezetimibe Intermediate-6
- MFCD13194798
- RefChem:403381
- C20H20FNO4
- CBQ74C2S2W
- SCHEMBL515189
- DTXSID50437685
- AVAZNWOHQJYCEL-MSOLQXFVSA-N
- CTK0H1387
- DTXCID70388509
- ACT07248
- AMX10119
- KS-00000PS3
- ZINC22059525
- AKOS015896433
- ACN-039798
- DS-4317
- FF57617
- CID10269700
- AC-26981
- AJ-80879
- AN-30441
- SC-86863
- SY028056
- AB0005574
- ST2402810
- 2-Oxazolidinone, 3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-, (4S)-
- CS-0037017
- Y6621
- J1.858.292I
- I11512
- EN300-7414353
- (4S)-3-[(5R)-5-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL]-4-PHENYL-1,3-OXAZOLIDIN-2-ONE
- 028F953
- A813293
- F237771
- I06-2021
- (4s)-4-phenyl-3-[(5s)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-1,3-oxazolidin-2-one
- (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl
- (S)-3-[(S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-2-oxazolidinone
- N0001-010877
- (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone
- (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-pentanoyl]-4-phenyl-oxazolidin-2-one
- 3-[(5s)-(4-fluorophenyl)-5-hydroxypentanoyl]-(4s)-phenyl-1,3-oxazolidin-2-one
- Ezetimibe impurity (3-[5-(4-Fluoro-phenyl)-5-(S)-hydroxy-pentanoyl]-4-(R)-phenyl-oxazolidin-2-one)
- (4R)-3-[5-(4-fluorophenyl)-5-hydroxy-pentanoyl]-4-phenyl-1,3-oxazolidin-2-one
- (4R)-4-Phenyl-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-1,3-oxazolidin-2-one
- (4S)-3-((5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl)-4-phenyl-2-oxazolidinone
- (4S)-3-((5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyl-1,3-oxazolidin-2-one
- (4S)-3-[(5S)-5-(4-Fluoro-phenyl)-5-hydroxy-pentanoyl]-4-phenyl-oxazolidin-2-one
- (4s)-3-[(5s)-5-(4-fluorophenyl)-5-hydroxy-1-oxo-pentyl]-4-phenyl-2-oxazolidinone
- (4S)-3-[(S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyloxazolidine-2-one
- (4S)-3-[(S)-5-Hydroxy-5-(4-fluorophenyl)pentanoyl]-4beta-phenyloxazolidine-2-one
- (4S)-3-[(S)-5-Hydroxy-5-(4-fluorophenyl)valeryl]-4beta-phenyloxazolidine-2-one
- (S)-3((S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
- (S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
- 2-Oxazolidinone, 3-[5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-, [S-(R*,R*)]-
- 2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-,(4S)-
- 3-(5S)-(4-Fluorophenyl)-5-hydroxypentanoyl-(4S)-phenyl-1,3-oxazolidin-2-one
- 3-[(5s)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-, (4s)- 2-oxazolidinone
- (4S)-3-[(5R)-5-(4-FLUOROPHENYL)-5- HYDROXYPENTANOYL]-4-PHENYL-1,3-OXAZOLIDIN-2-ONE
- (4S)-4-Phenyl-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-1,3-oxazolidin-2-one; [S-(R*,R*)]-3-[5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone; (S)-3-((S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
- 528565-93-7
- 606-165-0
- Ezetimibe impurity (3-[5-(4-Fluoro-phenyl)-5-(S)-hydroxy-pentanoyl]-4-(S)-phenyl-oxazolidin-2-one)
- Ezetimibe intermediate;2-Oxazolidinone, 3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-, (4S)-